# Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke

> **NCT03252626** · PHASE4 · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 950 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Alprostadil
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03252626
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-18
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 950 (ESTIMATED)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03252626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03252626, "Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03252626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*